Improvement of Pharmacological Properties of Irreversible Thyroid Receptor Coactivator Binding Inhibitors
- 26 May 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (13) , 3892-3901
Abstract
We have previously reported the discovery and preliminary structure activity relationships of a series of β-aminoketones that disrupt the binding of coactivators to TR. However, the most active compounds had moderate inhibitory potency and relatively high cytotoxicity, resulting in narrow therapeutic index. Additionally, preliminary evaluation of in vivo toxicology revealed a significant dose related cardiotoxicity. Here we describe the improvement of pharmacological properties of thyroid hormone receptor coactivator binding inhibitors. A comprehensive survey of the effects of substitutents in key areas of the molecule was carried out based on mechanistic insight from the earlier report. This study revealed that both electron withdrawing and hydrophobic substituents on the aromatic ring led to higher potency. On the other hand, moving from an alkyl to a sulfonyl alkyl side chain led to reduced cytotoxicity. Finally, utilization of amine moieties having low pKa’s resulted in lowered ion channel activity without any loss of pharmacological activity.Keywords
This publication has 29 references indexed in Scilit:
- Access and Binding of Local Anesthetics in the Closed Sodium ChannelMolecular Pharmacology, 2008
- Inhibitors of the Interaction of a Thyroid Hormone Receptor and Coactivators: Preliminary Structure−Activity RelationshipsJournal of Medicinal Chemistry, 2007
- High throughput solubility measurement in drug discovery and developmentAdvanced Drug Delivery Reviews, 2007
- Mimicry of phase I drug metabolism – novel methods for metabolite characterization and synthesisRapid Communications in Mass Spectrometry, 2007
- Design and synthesis of complementing ligands for mutant thyroid hormone receptor TRβ(R320H): a tailor-made approach toward the treatment of resistance to thyroid hormoneBioorganic & Medicinal Chemistry, 2005
- A Thyroid Hormone Antagonist That Inhibits Thyroid Hormone Action in VivoJournal of Biological Chemistry, 2002
- Mechanism of Thyroid Hormone ActionThyroid®, 2002
- Cloning and Characterization of Two Novel Thyroid Hormone Receptor β IsoformsMolecular and Cellular Biology, 2000
- A survey of Hammett substituent constants and resonance and field parametersChemical Reviews, 1991
- Eine Synthese von β‐KetonbasenArchiv der Pharmazie, 1917